High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23

Objective: Iron isomaltoside (Monofer(®)) is a high-dose intravenous iron preparation with good tolerability and efficacy in inflammatory bowel disease (IBD) patients with iron deficiency anaemia (IDA). This trial evaluates the safety and efficacy, including effect on intact fibroblast growth factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahlerup, Jens Frederik, Jacobsen, Bent A., van der Woude, Janneke, Bark, Lars-Åke, Thomsen, Lars L., Lindgren, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152597/
https://www.ncbi.nlm.nih.gov/pubmed/27326766
http://dx.doi.org/10.1080/00365521.2016.1196496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152597/
https://www.ncbi.nlm.nih.gov/pubmed/27326766
http://dx.doi.org/10.1080/00365521.2016.1196496

Ejemplares similares